IGM Biosciences Inc (IGMS)
8.85
-0.92
(-9.37%)
USD |
NASDAQ |
Nov 21, 16:00
8.75
-0.10
(-1.13%)
After-Hours: 17:45
IGM Biosciences Market Cap: 526.26M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 580.67M |
| November 19, 2024 | 567.29M |
| November 18, 2024 | 548.26M |
| November 15, 2024 | 563.13M |
| November 14, 2024 | 600.59M |
| November 13, 2024 | 663.03M |
| November 12, 2024 | 674.92M |
| November 11, 2024 | 765.90M |
| November 08, 2024 | 774.82M |
| November 07, 2024 | 854.50M |
| November 06, 2024 | 866.99M |
| November 05, 2024 | 941.32M |
| November 04, 2024 | 932.99M |
| November 01, 2024 | 964.51M |
| October 31, 2024 | 1.019B |
| October 30, 2024 | 1.046B |
| October 29, 2024 | 1.026B |
| October 28, 2024 | 1.060B |
| October 25, 2024 | 1.001B |
| October 24, 2024 | 941.65M |
| October 23, 2024 | 952.94M |
| October 22, 2024 | 1.037B |
| October 21, 2024 | 931.54M |
| October 18, 2024 | 993.96M |
| October 17, 2024 | 952.94M |
| Date | Value |
|---|---|
| October 16, 2024 | 842.37M |
| October 15, 2024 | 917.27M |
| October 14, 2024 | 998.71M |
| October 11, 2024 | 891.71M |
| October 10, 2024 | 825.72M |
| October 09, 2024 | 807.89M |
| October 08, 2024 | 864.96M |
| October 07, 2024 | 815.62M |
| October 04, 2024 | 916.08M |
| October 03, 2024 | 885.76M |
| October 02, 2024 | 856.04M |
| October 01, 2024 | 861.99M |
| September 30, 2024 | 983.26M |
| September 27, 2024 | 1.008B |
| September 26, 2024 | 940.79M |
| September 25, 2024 | 973.42M |
| September 24, 2024 | 1.002B |
| September 23, 2024 | 948.51M |
| September 20, 2024 | 958.59M |
| September 19, 2024 | 1.022B |
| September 18, 2024 | 987.66M |
| September 17, 2024 | 1.049B |
| September 16, 2024 | 939.61M |
| September 13, 2024 | 729.62M |
| September 12, 2024 | 675.64M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
230.04M
Minimum
Oct 31 2023
3.876B
Maximum
Feb 09 2021
1.229B
Average
895.93M
Median
Dec 02 2022
Market Cap Benchmarks
| Moderna Inc | 14.72B |
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 17.79M |
| iBio Inc | 22.42M |
| Theriva Biologics Inc | 3.561M |
Market Cap Related Metrics
| PS Ratio | 182.82 |
| Price to Book Value | 6.666 |
| Price | 8.85 |
| Earnings Yield | -40.79% |